Study of GVAX (With CY) and Pembrolizumab in MMR-p Advanced Colorectal Cancer
Clinical trial NCT02981524 · COMPLETED
Trial details
- NCT number
- NCT02981524
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-26
- Primary completion
- 2018-03-20
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.